Tanzania - English - Tanzania Medicinces & Medical Devices Authority

rusan pharma limited, india - nalbuphine - solution for injection - 20 mg

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

rusan pharma limited, india - nalbuphine - solution for injection - 10 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (austria) - nalbuphine hydrochloride - solution for injection - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - nalbuphine hydrochloride - solution for injection - 10mg/1ml

United States - English - NLM (National Library of Medicine)

braeburn pharmaceuticals - buprenorphine hydrochloride (unii: 56w8mw3en1) (buprenorphine - unii:40d3scr4gz) - buprenorphine 80 mg - probuphine is indicated for the maintenance treatment of opioid dependence in patients who have achieved and sustained prolonged clinical stability on low-to-moderate doses of a transmucosal buprenorphine-containing product (i.e., doses of no more than 8 mg per day of subutex or suboxone sublingual tablet or generic equivalent). probuphine should be used as part of a complete treatment program to include counseling and psychosocial support. probuphine is not appropriate for new entrants to treatment and patients who have not achieved and sustained prolonged clinical stability, while being maintained on buprenorphine 8 mg per day or less of a subutex or suboxone sublingual tablet equivalent or generic equivalent. probuphine is contraindicated in patients with a history of hypersensitivity to buprenorphine or any other ingredients in probuphine (e.g., eva). [see warnings and precautions (5.11)]. risk summary the data on use of buprenorphine, the active ingredient in probuphine implant, in pregnancy, are limited

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

intega sdn. bhd. - dinalbuphine sebacate -

Ireland - English - HPRA (Health Products Regulatory Authority)

orpha-devel handels und vertriebs gmbh - nalbuphine hydrochloride - solution for injection - 10 milligram(s)/millilitre - morphinan derivatives; nalbuphine

Canada - English - Health Canada

elvium life sciences - methylphenidate hydrochloride - capsule (extended release) - 15mg - methylphenidate hydrochloride 15mg - respiratory and cns stimulants

Canada - English - Health Canada

elvium life sciences - methylphenidate hydrochloride - capsule (extended release) - 20mg - methylphenidate hydrochloride 20mg - respiratory and cns stimulants

Canada - English - Health Canada

elvium life sciences - methylphenidate hydrochloride - capsule (extended release) - 10mg - methylphenidate hydrochloride 10mg - respiratory and cns stimulants